Frequently cited gaps include standardized formulations, validated pharmacokinetics, formal toxicology, independent replication, controlled human trials, and long-term safety data
Skip copper peptides
Cagrilintide may promote fat utilization and reduce fat storage, contributing to favorable body composition changesreduced adiposity alongside preserved lean mass
Digestive Problems: Increased risk of stomach cancer and gastric polyps
Theyre signaling molecules that play a role in various physical processes
Reasonable candidates include: Mild to moderate IBD as an adjunct (never as sole therapy, always with GI oversight) IBS with a documented inflammatory component Post-infectious gut dysfunction where both tissue damage and persistent low-grade inflammation are present Mixed presentations, heartburn plus intestinal sensitivity plus food reactivity, where the clinical picture suggests multiple mechanisms Where this falls apart is when people treat it as a silver bullet
:format(webp))
